| Name |
| |
Mitsuyasu Kato |
| |
|
| Affiliation |
| |
University of Tsukuba , Graduate School of Comprehensive Human Sciences
Experimental Pathology, Field of Molecular Pathology, Doctoral Program in Life System Medical Sciences ( Institute of Basic Medical Sciences)
|
| |
|
| Title |
| |
Professor
|
| |
|
| Academic degrees |
| |
MD (Tohoku University)
PhD (Tohoku University) |
| |
|
| Research Fields |
| |
Experimental Pathology, Molecular Cell Biology
|
| |
|
| Research Subjects |
| |
Roles of transforming growth factor-βin cancer and other human diseases
|
| |
|
| Academic Society Membership |
| |
-Committee member, Japanese Society of Pathology
-Committee member, Japanese Cancer Association
-Molecular Biology Society of Japan
|
| |
|
| Academic Publications |
| |
Suzuki H , et al . c-Ski inhibits the TGF- βsignaling pathway through stabilization of inactive Smad complexes on Smad binding elements. Oncogene. 2004; 23: 5068-5076. |
| |
Itoh F, et al . Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells. EMBO J., 2004; 23: 541-551.
|
| |
Sasaki T, et al . Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor- β;-induced repression of c- myc . Cancer Res. 2003; 63: 801-806. |
| |
Hamamoto T, et al . Compound disruption of Smad2 accelerates malignant progression of intestinal tumors in Apc knockout mice. Cancer Res. 2002; 62: 5955-5961. |
| |
Yagi K, et al . c-myc is a downstream target of Smad pathway. J. Biol. Chem. 2002; 277: 854-861.
|
| |
|
| Awards |
| |
|
| |
|
| tel,fax |
| |
tel : 029-853-3159, 3944 |
| |
fax : 029-853-3159 |
| |
|
| E-mail Address |
| |
mit-kato md.tsukuba.ac.jp
|